← All organizations
Highest phase reached
Phase 1
First clinical trial
Jul 6, 2020Last known activity
Sep 1, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT05009498Reponsible party - principal investigatorN/ASep 1, 2021
- NCT05009498Overall official - principal investigatorN/ASep 1, 2021
- NCT05009498Lead sponsorN/ASep 1, 2021
- NCT04488367Reponsible party - principal investigatorEarly Phase 1Jul 6, 2020
- NCT04488367Lead sponsorEarly Phase 1Jul 6, 2020
Details
- Last known activity
- Sep 1, 2021